Hualan Biological Engineering Stock Forecast for 2023 - 2025 - 2030

Updated on 03/27/2024

Stock Rating
18
Price Target
¥25.97
Consensus
Outperform
Upside
29.91%
Analysts
0
Stock Rating
18
Upside
29.91%
Analysts
0
Price Target
¥25.97

Hualan Biological Engineering Stock Forecast and Price Target

Based on the current earnings figures, this year's price targets for Hualan Biological Engineering were recently set by distinguished experts, with an average mark of ¥25.97. If it reached this goal, it would represent a potential upside of approximately 29.91% from the previous closing price in March, 2024. The high end is ¥30.00, and the low is ¥19.00. Even if not interested in 002007 stock, you may want to be aware of its competitors.

¥25.97

29.91% Upside

Outperform
Outperform

Hualan Biological Engineering Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Hualan Biological Engineering's Price has gone down from ¥32.66 to ¥0.00 – a 100.00% drop. In the next year, analysts predict that Fair Value will reach ¥38.30 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
¥38.30
2025 Fair Value Forecast
¥44.76
2026 Fair Value Forecast
¥42.61
2027 Fair Value Forecast
¥27.07
2028 Fair Value Forecast
¥31.41
2029 Fair Value Forecast
¥36.50
2030 Fair Value Forecast
¥40.10
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAX Stock Forecast Baxter International Inc Outperform 17
$43.48 Buy/Sell $44.86 3.50%
600161 Stock Forecast Beijing Tiantan Biological Pro... Buy 18
¥28.10 Buy/Sell ¥31.28 12.03%
GRF Stock Forecast Grifols Outperform 18
8.48€ Buy/Sell 18.48€ 116.98%
300294 Stock Forecast China Resources Boya Bio-pharm... Outperform 16
¥28.23 Buy/Sell ¥35.07 21.68%
002880 Stock Forecast Shenzhen Weiguang Biological P... Buy 18
¥28.41 Buy/Sell ¥42.00 47.84%

Hualan Biological Engineering Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Hualan Biological Engineering's Revenue has gone down from ¥5.02B to ¥4.52B – a 10.08% drop. In the next year, analysts predict that Revenue will reach ¥6.37B – an increase of 40.96%. For the next seven years, the forecast is for Revenue to grow by 39.90%.

2024 Rev Forecast
¥6.37B
2025 Rev Forecast
¥7.21B
2026 Rev Forecast
¥6.19B
2027 Rev Forecast
¥5.69B
2028 Rev Forecast
¥5.95B
2029 Rev Forecast
¥6.36B
2030 Rev Forecast
¥6.32B

Hualan Biological Engineering Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Hualan Biological Engineering's Dividend per Share has fallen from ¥0.30 to ¥0.30 – a 0.00% decrease. In the next year, analysts are expecting an increase in Dividend per Share, predicting it will reach ¥0.38 – an increase of 26.67%. The Hualan Biological Engineering forecast is for Dividend per Share to reach ¥0.34 or grow by 14.29%.

2024 DPS Forecast
¥0.38
2025 DPS Forecast
¥0.39
2026 DPS Forecast
¥0.32
2027 DPS Forecast
¥0.32
2028 DPS Forecast
¥0.34
2029 DPS Forecast
¥0.36
2030 DPS Forecast
¥0.34

Hualan Biological Engineering Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
¥1.43B
2025 FCF Forecast
¥2.36B
2026 FCF Forecast
¥1.99B
2027 FCF Forecast
¥2.85B
2028 FCF Forecast
¥2.56B
2029 FCF Forecast
¥3.46B
2030 FCF Forecast
¥4.09B

Hualan Biological Engineering EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Hualan Biological Engineering's EBITDA has decreased by 31.38%, going from ¥2.18B to ¥1.50B. In the next year, analysts expect EBITDA to reach ¥2.41B – an increase of 61.14%. For the next seven years, the forecast is for EBITDA to grow by 64.52%.

2024 EBITDA Forecast
¥2.41B
2025 EBITDA Forecast
¥2.79B
2026 EBITDA Forecast
¥2.49B
2027 EBITDA Forecast
¥2.16B
2028 EBITDA Forecast
¥2.26B
2029 EBITDA Forecast
¥2.43B
2030 EBITDA Forecast
¥2.46B

Hualan Biological Engineering EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Hualan Biological Engineering's EBIT has decreased from ¥2.00B to ¥1.22B – a 38.78% drop. The next year looks promising for Hualan Biological Engineering, with analysts predicting EBIT of ¥2.26B – an increase of 84.36%. Over the next seven years, experts anticipate that Hualan Biological Engineering's EBIT will grow at a rate of 289.34%.

2024 EBIT Forecast
¥2.26B
2025 EBIT Forecast
¥2.64B
2026 EBIT Forecast
¥2.89B
2027 EBIT Forecast
¥3.28B
2028 EBIT Forecast
¥3.71B
2029 EBIT Forecast
¥4.20B
2030 EBIT Forecast
¥4.76B

Hualan Biological Engineering EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Hualan Biological Engineering's EPS has gone down from ¥0.81 to ¥0.00 – a 100.00% drop. In the next year, analysts predict that EPS will reach ¥0.95 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
¥0.95
2025 EPS Forecast
¥1.11
2026 EPS Forecast
¥1.06
2027 EPS Forecast
¥0.67
2028 EPS Forecast
¥0.78
2029 EPS Forecast
¥0.91
2030 EPS Forecast
¥0.99